34 Manganese exposure produces Parkinson's-like neurological symptoms, suggesting a selective 35 dysregulation of dopamine transmission. It is unknown, however, how manganese accumulates in 36 dopaminergic brain regions or how it regulates the activity of dopamine neurons. Our in vivo 37 studies suggest manganese accumulates in dopamine neurons of the ventral tegmental area and 38 substantia nigra via nifedipine-sensitive Ca 2+ channels. Manganese produces a Ca 2+ channel-39 mediated current which increases neurotransmitter release and rhythmic firing activity of 40 dopamine neurons. These increases are prevented by blockade of Ca 2+ channels and depend on 41 downstream recruitment of Ca 2+ -activated potassium channels to the plasma membrane. These 42 findings demonstrate the mechanism of manganese-induced dysfunction of dopamine neurons, and 43 reveal a potential therapeutic target to attenuate manganese-induced impairment of dopamine 44 transmission. 45 46 Significance Statement 47Manganese is a trace element critical to many physiological processes. Overexposure to 48 manganese is an environmental risk factor for neurological disorders such as a Parkinson's disease-49 like syndrome known as manganism. We found manganese dose-dependently increased the 50 excitability of dopamine neurons, decreased the amplitude of action potentials, and narrowed 51 action potential width. Blockade of Ca 2+ channels prevented these effects as well as manganese 52 accumulation in the mouse midbrain in vivo. Our data provide a potential mechanism for 53 manganese-regulation of dopaminergic neurons. 54 55Manganese is a trace element critical to many physiological and developmental processes, 57 including the regulation of macronutrient metabolism, blood glucose, cellular energy, reproduction, 58 digestion, and bone growth (Greene and Madgwick, 1988; Erikson et al., 2005). Manganese is a 59 cofactor for several enzymatic processes and a constituent of metalloenzymes, including arginase, 60 pyruvate carboxylase, and manganese-containing superoxide dismutase (Ashner and Aschner, 61 2005; Ashner et al., 2007; Guilarte, 2010). Except in children on long-term parenteral nutrition or 62 individuals with mutations in the metal transporter SLC39A8 gene, manganese deficiencies are 63 seldom reported (Greene and Madgwick, 1988; Zogzas and Mukhopadhyay, 2017). In contrast, 64 excess manganese accumulation in the brain following environmental exposure is implicated in 65 abnormalities related to the dopaminergic system, including Parkinson-like motor dysfunction 66 (Jankovic, 2005), ataxia (Soriano et al., 2016), and hallucinations (Verhoeven et al., 2011). Animal 67 models of manganism have shown that a single large exposure or prolonged moderate exposure to 68 excess manganese is detrimental to the basal ganglia function (Michalke and Fernsebner 2014; 69 Olanow, 2004), albeit with less understood mechanisms.70 71 Manganese can enter the central nervous system (CNS) through the cerebral spinal fluid or by 72 crossing cerebral capillary...